[HTML][HTML] Long-term follow-up of patients receiving neoadjuvant treatment modalties for soft tissue sarcomas of the extremities

M Rauch, A Agaimy, S Semrau, A Willner, O Ott… - Cancers, 2021 - mdpi.com
Simple Summary Neoadjuvant radiotherapy has gained popularity as a treatment strategy
for locally advanced soft tissue sarcoma of the extremities. However, little is yet known about …

[HTML][HTML] Neoadjuvant Chemoradiation Herapy for Soft Tissue Sarcomas of the Extremities

SA Junior, F de Oliveira Ferreira, BM Rossi… - Clinics, 2009 - Elsevier
INTRODUCTION AND OBJECTIVE Neoadjuvant and adjuvant therapies for soft tissue
sarcomas of the extremities are still controversial. The aim of this study was to analyze the …

[HTML][HTML] Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities

KK Curtis, JB Ashman, CP Beauchamp, AJ Schwartz… - Radiation …, 2011 - Springer
Background Neoadjuvant chemoradiation (NCR) prior to resection of extremity soft tissue
sarcoma (STS) has been studied, but data are limited. We present outcomes with NCR using …

Preoperative radiotherapy with concomitant chemotherapy in extremity soft tissue sarcomas: long-term results of a single center

U Yilmaz, S Kamer, H Kaya, D Sabah, UA Sanli… - Strahlentherapie und …, 2023 - Springer
Purpose To assess oncological outcomes of patients receiving neoadjuvant
radiochemotherapy (RCT) for soft tissue sarcoma (STS) of the extremities. Methods Patients …

Long‐term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high‐risk, high‐grade, soft tissue sarcomas of the …

WG Kraybill, J Harris, IJ Spiro, DS Ettinger… - Cancer, 2010 - Wiley Online Library
BACKGROUND: The use of neoadjuvant and adjuvant chemotherapy in soft tissue
sarcomas is controversial. This is a report of long‐term (≥ 5 years) follow‐up in patients with …

Adjuvant and neoadjuvant chemotherapy for soft tissue sarcoma of the extremities

R Maki - UpToDate. http://www. uptodate. com/contents/adjuvant … - uptodate.com
Soft tissue sarcomas (STS) are uncommon malignant tumors that arise from extraskeletal
connective tissues, including the peripheral nervous system. They can arise at any body site …

Evaluation of two modalities of perioperative treatment in the management of extremity and truncal soft tissue sarcomas: neoadjuvant concurrent chemoradiotherapy …

J Attal, B Cabarrou, T Valentin, JP Nesseler… - Strahlentherapie und …, 2021 - Springer
Purpose Patients with locally advanced grade 2–3 extremity/truncal soft tissue sarcomas
(STS) are at high risk of recurrence. The objective of this study was to assess the efficacy …

Preoperative therapy for extremity soft tissue sarcomas

LE Davis, CW Ryan - Current treatment options in oncology, 2015 - Springer
Opinion statement High-risk soft tissue sarcomas (STS) are defined as large (> 5 cm),
intermediate/high-grade tumors and can carry a> 50% risk of death from metastases. A …

Assessing the role of neoadjuvant chemotherapy in primary high-risk truncal/extremity soft tissue sarcomas: an analysis of the multi-institutional US sarcoma …

MY Zaidi, CG Ethun, TB Tran, G Poultsides… - Annals of Surgical …, 2019 - Springer
Background The role of neoadjuvant chemotherapy (NCT) for high-risk soft tissue sarcoma
(STS) is questioned. This study aimed to define which patients may experience a survival …

Looking for answers: the current status of neoadjuvant treatment in localized soft tissue sarcomas

MJ Nathenson, E Sausville - Cancer chemotherapy and pharmacology, 2016 - Springer
Purpose Sarcomas are a rare and heterogeneous variant of cancer. The standard of care
treatment involves surgical resection with radiation in high-risk patients. Despite appropriate …